secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K/A
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001437749-24-027621
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva Pharmaceuticals raises $3.8M net in public offering of common stock and warrants
--------------------------------------------------------------------------------

- Net proceeds from offering updated to $3.8M; closed Aug 22, 2024.
- Sold 3,276,262 shares at $1.05/share along with warrants to purchase up to 4,761,905 shares at $0.7964.
- Also issued pre-funded warrants for 1,485,643 shares and underwriter warrants for 238,095 shares at $1.3125.
- Existing warrants from 2021 and 2023 amended: exercise price lowered to $0.7964, expiration extended to 5 years.
- Titan Partners Group underwriter; 8.0% commission and expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924027621/0001437749-24-027621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924027621/rvph20240822_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-027621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer